Mobile

Result of your search per sponsor: Gastrotech Pharma A/S

Woman and Man Max 99 years
Gastrotech Pharma A/S Update Il y a 4 ans

A randomized, double-blind, placebo controlled, cross-over, multi-center study to assess the effect of the GLP-1 analogue LY307161 in patients suffering from Irritable Bowel Disease To test the hypothesis that LY307161, will reduce the acute abdominal pain attacks in patients suffering from irritable bowel syndrome (IBS). The primary endpoint will be the proportion of responders ...

  • Country None
  • organs None
  • Specialty None
Closed trial
More information